Failure of dietary oligofructose to prevent antibiotic-associated diarrhoea

Alimentary Pharmacology and Therapeutics

Volumn 21, Issue 4, 2005, Pages 469-477

  Lewis, S ^a,c   Burmeister, S ^a   Cohen, S ^b   Brazier, J ^b   Awasthi, A ^c  

^a ADDENBROOKE S HOSPITAL   (United Kingdom)

^b UNIVERSITY HOSPITAL OF WALES   (United Kingdom)

^c DERRIFORD HOSPITAL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

AMOXICILLIN; AMOXICILLIN PLUS CLAVULANIC ACID; AMPICILLIN; ANTIBIOTIC AGENT; CARBOHYDRATE DERIVATIVE; CEPHALOSPORIN DERIVATIVE; CLARITHROMYCIN; DOXYCYCLINE; OLIGOFRUCTOSE; PLACEBO; UNCLASSIFIED DRUG;

AGED; ANTIBIOTIC THERAPY; ARTICLE; BIFIDOBACTERIACEAE; CLINICAL TRIAL; CLOSTRIDIUM DIFFICILE; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DIARRHEA; DIET SUPPLEMENTATION; DOUBLE BLIND PROCEDURE; ELDERLY CARE; FECES MICROFLORA; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; TREATMENT FAILURE;

AGED; AGED, 80 AND OVER; ANTI-BACTERIAL AGENTS; CLOSTRIDIUM DIFFICILE; CLOSTRIDIUM INFECTIONS; DIARRHEA; DOUBLE-BLIND METHOD; FECES; FEMALE; HUMANS; MALE; OLIGOSACCHARIDES;

EID: 14644435062     PISSN: 02692813     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1365-2036.2005.02304.x     Document Type: Article

References (29)

1. Van der Waaij D. Colonisation resistance of the digestive tract: clinical consequences and implications. J Antimicrob Chemother 1982; 70: 263-79.
2. Bullen CL, Willis AT. Resistance of the breast-fed infant to gastro-enteritis. Br Med J 1971; 3: 338-43.
3. Wang X, Gibson GR. Effects of in vitro fermentation of oligofructose and inulin by bacteria growing in the human large intestine. J Appl Bacteriol 1993; 75: 373-80.
4. Gibson GR, Wang X. Regulatory effects of bifidobacteria on the growth of colonic bacteria. J Appl Bacteriol 1994; 77: 412-20.
5. Marteau P, Pochart P, Flourie B, et al. Effect of chronic ingestion of a fermented dairy product containing Lactobacillus acidophilus and Bifidobacterium bifidum on metabolic activities of the colonic flora in humans. Am J Clin Nutr 1990; 52: 685-8.
6. Colombel JF, Cortot A, Neut C, Romond C. Yoghurt with Bifidobacterium longum reduces erythromycin-induced gastrointestinal effects. Lancet 1987; ii: 43.
7. Reddy BS, Rivenson A. Inhibitory effect of Bifidobacterium longum on the colon, mammary and liver carcinogenesis induced by 2 amino-3-metylimidazo[4, 5-f] quinoline, a food mutagen. Cancer 1993; 53: 3914-8.
8. Koo M, Rao AV. Long-term effect of bifidobacteria and Neosugar on precursor lesions of colonic cancer in CF1 mice. Nutr Rev 1991; 51: 137-46.
9. Wells CL, Maddaus LA, Jechorek RP, Simmons RL. Role of intestinal anaerobic bacteria in colonisation resistance. Eur J Clin Microbiol Infect Dis 1988; 7: 107-13.
10. Yamazaki S, Kamimura H, Momose H, Kawashima T, Ueda K. Protective effect of Bifidobacterium monoassociation against lethal activity of E. coli. Bifidobacteria Microflora 1982; 1: 55-60.
11. Gorbach SL, Chang TW, Goldin B. Successful treatment of relapsing Clostridium difficile colitis with Lactobacillus GG. Lancet 1987; 2: 1519.
12. Chapoy P. Traitement des diarrhées aiguës infantiles: essai contrôlé de Saccharomyces boulardii. Ann Pédiatr 1985; 32: 561-3.
13. Kimmey MB, Elmer GW, Surawicz CM, McFarland LV. Prevention of further recurrences of Clostridium difficile colitis with Saccharomyces boulardii. Dig Dis Sci 1990; 35: 897-901.
14. Saint-Marc T, Rossello-Prats L, Touraine JL. Saccharomyces boulardii dans le traitement des diarrhées du SIDA. Ann Med Interne 1991; 142: 64-5.
15. Surawicz CM, Elmer G, Speelman P, McFarland LV, Chinn J, Belle G. Prevention of antibiotic-associated diarrhea by Saccharomyces boulardii: a prospective study. Gastroenterology 1989; 96: 981-8.
16. Lewis SJ, Freedman AR. The use of biotherapeutic agents in the prevention and treatment of gastrointestinal disease. Aliment Pharmacol Ther 1998; 12: 807-22.
17. Blehaut H, Massot J, Elmer GW, Levey RH. Disposition kinetics of Saccharomyces boulardii in man and rat. Biopharm Drug Dispos 1989; 10: 353-64.
18. Molis C, Flourié B, Ouarne F, et al. Digestion, excretion, and energy value of fructooligosaccharides in healthy humans. Am J Clin Nutr 1996; 64: 324-8.
19. Gibson GR, Beatty ER. Wang X, Cummings JH. Selective stimulation of bifidobacteria in the human colon by oligofructose and inulin. Gastroenterology 1995; 108: 975-82.
20. Wolf BW, Meulbroek JA, Jarvis KP, Wheeler KP, Garleb KA. Dietary supplementation with fructooligosaccharides increase survival time in a hamster model of Clostridium difficile-colitis. Biosci Microflora 1997; 16: 59-64.
21. Gerding DN, Olson MM, Peterson LR, et al. Clostridium difficile-associated diarrhea and colitis in adults. Arch Intern Med 1986; 146: 95-100.
22. Beerens H. An elective and selective isolation medium for Bifidobacterium spp. Lett Appl Microbiol 1990; 11: 155-7.
23. Brazier JS. The diagnosis of Clostridium difficile associated disease. J Antimicrob Chemother 1998; 41 (Suppl. C): 29-40.
24. Bovee-Oudenhoven IMJ, Bruggencate JJM, Lettink-Wissink MLG, Van der Meer R. Dietary fructo-oligosaccharides and lactulose inhibit intestinal colonisation but stimulate translocation of Salmonella in rats. Gut 2003; 52: 1572-8.
25. Ten Bruggencate SJ, Bovee-Oudenhoven IM, Lettink-Wissink ML, Katan MB, Van Der Meer R. Dietary fructo-oligosaccharides and inulin decrease resistance of rats to Salmonella: protective role of calcium. Gut 2004; 53: 530-5.
26. Orrhage K, Sjostedt S, Nord CE. Effects of supplements with lactic acid bacteria and oligofructose on the intestinal microflora during administration of cefpodoxime proxetil. J Antimicrob Chemother 2000; 46: 603-12.
27. Cummings JH, Christie C, Cole TJ. A study of fructo-oligosaccharides in the prevention of travellers diarrhoea. Aliment Pharmacol Ther 2001; 15: 1139-45.
28. Rao SS, Edwards CA, Austen C. Impaired colonic fermentation of carbohydrate after ampicillin. Gastroenterology 1998; 94: 928-32.
29. Cunningham R, Dale B, Undy B, Gaunt N. Proton pump inhibitors as a risk factor for Clostridium difficile diarrhoea. J Hosp Infect 2003; 54: 243-5.